TABLE 4.
Grapefruit (n = 14) |
Control (n = 15) |
||||
Pre | Post | Pre | Post | P value2 | |
Plasma sVCAM-1, μg/L | 666 ± 134 | 650 ± 145 | 603 ± 86 | 594 ± 94 | 0.84 |
Plasma hsCRP, mg/L | 2.3 ± 1.7 | 2.0 ± 1.0 | 3.1 ± 1.5 | 3.1 ± 1.6 | 0.11 |
Urinary F2-isoprostanes, ng/mg creatinine | 14.3 ± 6.7 | 12.0 ± 4.5 | 15.0 ± 6.9 | 18.3 ± 10.9 | 0.06 |
Values are means ± SDs. No differences were found between groups at baseline for any biomarker. Paired t tests were used to determine the change in biomarker within each randomization group, although no significant differences were found; P < 0.05. hsCRP, high-sensitivity C-reactive protein; sVCAM-1, soluble vascular cellular adhesion molecule 1.
P values were derived from linear regression models comparing differences between randomization arms, postintervention, after adjustment for baseline value of biomarker.